Home

T. Rowe Price Investment Management reported a 3.3% stake in Prime Medicine PRME · 5,995,183 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
3.3%
Last report
5.3% · filed 25/11/14
Shares held
5,995,183 sh
Class
COMMON STOCK
Event date
25/12/31
Filed
26/02/17

3.3% stake · below 5%

Stake
3.3%
Last report
5.3%
Since last report
−2.0pp

Prime Medicine trades, last 26 weeks

What else happened in Prime Medicine around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

T. Rowe Price Investment Management's other 5% stake reports